|
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RECRUITINGPhase 2Sponsored by Eli Lilly and Company
Actively Recruiting
PhasePhase 2
SponsorEli Lilly and Company
Started2026-08-07
Est. completion2028-05
Eligibility
Age40 Years – 75 Years
Healthy vol.Accepted
Locations18 sites
View on ClinicalTrials.gov →
NCT07759245
Summary
The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.
Eligibility
Age: 40 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: * Have a physician diagnosis of Chronic Obstructive Pulmonary Disease (COPD), at least 12 months prior to screening who meet the following criteria: * Current or former smokers with a smoking history of greater than or equal to (≥) 10 pack-years * Moderate-to-severe COPD (post-Bronchodilator (BD) Forced Expiratory Volume in 1 Second (FEV₁)/forced vital capacity (FVC) less than (\<) 70 percent (%) * Modified Medical Research Council Dyspnea Scale (mMRC-DS) grade ≥2 * Exacerbation history of ≥2 moderate or ≥1 severe exacerbations within the year prior to inclusion. * Background double therapy \[long-acting β₂-agonists (LABA) + long-acting muscarinic antagonists (LAMA)\] or triple therapy \[inhaled corticosteroids (ICS) + LABA + LAMA)\] for 3 months prior to randomization with a stable dose of medication for ≥1 month prior to screening. Exclusion Criteria: * Have a known pre-existing, clinically important lung condition other than COPD. * Have a current or recent acute, active infection before screening and up to randomization.
Conditions2
COPDPulmonary Disease, Chronic Obstructive
Interventions1
Locations18 sites
Institute of HealthCare Assessment d/b/a Apex Clinical Research
619-582-5564
Find trials near these locations
COPD trials in San DiegoCOPD trials in DenverCOPD trials in MiamiCOPD trials in OrlandoCOPD trials in IndianapolisCOPD trials in BostonCOPD trials in HoustonAll trials in AlabamaAll trials in CaliforniaAll trials in ColoradoAll trials in FloridaAll trials in IllinoisAll trials in IndianaAll trials in MassachusettsAll trials in MichiganAll trials in MinnesotaAll trials in PennsylvaniaAll trials in TexasAll trials in Washington
Related trials
- A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder — Eli Lilly and Company
- A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma — Eli Lilly and Company
- A Study of Brenipatide in Adult Participants With Major Depressive Disorder — Eli Lilly and Company
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorEli Lilly and Company
Started2026-08-07
Est. completion2028-05
Eligibility
Age40 Years – 75 Years
Healthy vol.Accepted
Locations18 sites
View on ClinicalTrials.gov →
NCT07759245